The latest price target for Sophia Genetics (NASDAQ:SOPH) was reported by RBC Capital on August 7, 2024. The analyst firm set a price target for $7.00 expecting SOPH to rise to within 12 months (a possible 105.88% upside). 6 analyst firms have reported ratings in the last year.

The latest analyst rating for Sophia Genetics (NASDAQ:SOPH) was provided by RBC Capital, and Sophia Genetics maintained their outperform rating.

There is no last upgrade for Sophia Genetics

There is no last downgrade for Sophia Genetics.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sophia Genetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sophia Genetics was filed on August 7, 2024 so you should expect the next rating to be made available sometime around August 7, 2025.

While ratings are subjective and will change, the latest Sophia Genetics (SOPH) rating was a maintained with a price target of $8.00 to $7.00. The current price Sophia Genetics (SOPH) is trading at is $3.40, which is out of the analyst’s predicted range.